Halozyme Therapeutics
HALO
#2384
Rank
NZ$12.77 B
Marketcap
NZ$108.27
Share price
1.64%
Change (1 day)
-3.15%
Change (1 year)

Halozyme Therapeutics (HALO) - Total assets

Total assets on the balance sheet as of December 2025 : NZ$4.33 Billion

According to Halozyme Therapeutics's latest financial reports the company's total assets are NZ$4.33 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Halozyme Therapeutics - Total assets on balance sheet (from 2002 to 2025)

Total assets by year

Year Total assets Change
2025-12-31NZ$4.36 B19.17%
2024-12-31NZ$3.65 B33.5%
2023-12-31NZ$2.74 B-5.51%
2022-12-31NZ$2.90 B79.38%
2021-12-31NZ$1.61 B101.18%
2020-12-31NZ$0.80 B-4.34%
2019-12-31NZ$0.84 B28.02%
2018-12-31NZ$0.65 B-10.35%
2017-12-31NZ$0.73 B93.92%
2016-12-31NZ$0.37 B42.14%
2015-12-31NZ$0.26 B25.39%
2014-12-31NZ$0.21 B71.01%
2013-12-31NZ$0.12 B-24.36%
2012-12-31NZ$0.16 B94.38%
2011-12-31NZ$84.25 M-28.84%
2010-12-31NZ$0.11 B11.47%
2009-12-31NZ$0.10 B-19.49%
2008-12-31NZ$0.13 B-2.32%
2007-12-31NZ$0.13 B106.45%
2006-12-31NZ$65.42 M118.02%
2005-12-31NZ$30 M30.53%
2004-12-31NZ$22.98 M2208.83%
2003-12-31NZ$0.99 M125.99%
2002-12-31NZ$0.44 M600.24%
2001-12-31NZ$0.06 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
NZ$342.02 B 7,788.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$357.38 B 8,142.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$193.11 B 4,353.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$255.75 B 5,798.74%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
NZ$34.43 B 694.16%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ$0.84 B-80.41%๐Ÿ‡บ๐Ÿ‡ธ USA